TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Word recognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change From Baseline in ADAS-Cog12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of participants with successful lentiviral vector transduced CD34+ stem cell engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transplant-related mortality within 100 days and within 1 year after reinfusion of KL003 drug product
Endpoint domain: Mortality/survival
Primary endpoint: The number, frequency and severity of adverse events (AE) within 1 year after reinfusion of KL003 drug products
Endpoint domain: Adverse events/effects
Primary endpoint: change in fat free mass (FFM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in fat mass (FM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute change in Simple Endoscopic Score for Crohn's disease (SES-CD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Luteinizing hormone (LH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Stoma care skills
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in mean nocturnal systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Early-phase insulin secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Usability of WELMO vest
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent Change From Baseline in Total Vitiligo Area Scoring Index (T-VASI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of unsolicited, treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of new-onset chronic diseases (NOCDs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of medically attended adverse events (MAAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of solicited local site and systemic reactogenicity events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of individuals with HIV-1 RNA <50 copies/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of skin hydration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: BMI at Three Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cone Contrast Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cone Contrast Naming Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Electrodiagnostic Testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spatial parameters of gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angular displacement of joint in gait cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: P1NP level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient self-efficacy relating to diabetes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diabetes knowledge questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Time to obtain the maximum concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of S086 tablets in treating Chronic heart failure with reduced ejection fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety (any potential side effects)
Endpoint domain: Adverse events/effects
Primary endpoint: maximum oxygen consumption (VO2MAX)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pembrolizumab efficiency at Month 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cell-mediated immunity (CD4+ and CD8+ T cell against herpes zoster)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Wong-Baker Facial Expression Rating Scale (WB-FRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in Peroneal eccentric strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in Peroneal endurance parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Viscoelastic hemostasis analysis results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: PrEP/ART Adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Methamphetamine Abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of SUZ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve From the Time of Dosing to the Last Measurable Concentration (AUC0-tlast) of SUZ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve From the Time of Dosing Extrapolated to Infinity (AUC0-inf) of SUZ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of device-related or sensor insertion/removal procedure-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of foreign body reaction due intra-gastrointestinal insertion
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of GI symptoms, i.e. inflammation, infection, diarrhea, bowel obstruction, and ileus
Endpoint domain: Adverse events/effects
Primary endpoint: Total consumption of intravenous anesthetic drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Treatment Related Diarrhea
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of Treatment Related Diarrhea
Endpoint domain: Adverse events/effects
Primary endpoint: Causality of Treatment Related Diarrhea
Endpoint domain: Adverse events/effects
Primary endpoint: Temperature difference between affected side and contralateral side
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mean pain level
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: therapeutic effect of oral levetiracetam on febrile convulsions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: therapeutic effect of intermittent diazepam on febrile convulsions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Clinical Symptoms Severity of Contamination-Based OCD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute angular error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative angular error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variable angular error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: auditory attention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: language
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: perceptual reasoning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Pressure pain threshold PPT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First Pass Reperfusion Effect (FPE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in anxiety (measured via the State Trait Anxiety Inventory - STAI-6)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number and Proportion of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Visual Analog Scale (VAS) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intraoperative cardiac output measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: number of participants enrolled
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: group attendance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: group completion
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Perceptions and awareness related to obesity management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Behaviours related to obesity management
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Triggers for requesting medical therapy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in consumption of sugar - sweetened beverages and juice
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in consumption of hypercaloric foods
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in screen time spent by children
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Peripheral oxygen desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: CDI reinfection
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of complete responses to therapy (complete metabolic response)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline Weight at 1 month
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Two-Years Overall Survival Rate
Endpoint domain: Mortality/survival
Primary endpoint: 24 hours mortality
Endpoint domain: Mortality/survival
Primary endpoint: Number of RNA transcripts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurodevelopment at 18 months post enrollment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Plasma Nicotine Concentration Pharmacokinetic (PK) Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physiological Heart Rate (HR) Assessment-HTP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physiological Heart Rate (HR) Assessment-UBCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Life-threatening adverse events attributable to study drugs
Endpoint domain: Adverse events/effects
Primary endpoint: Long-term neurological function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Liverpool Elbow Scoring Questionnaire (LES)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rivermead Post-concussion Questionnaire (RPQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Utrecht Scale for Evaluation of Rehabilitation-Participation (USER-P)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Fugl-Meyer Assessment - Upper Extremity (FMA-UE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lowest number of errors on executive tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of maximum interincisal opening (MIO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Puncture-free Survival (PuFS)
Endpoint domain: Mortality/survival
Primary endpoint: Change in the Gastrointestinal Symptom Rating Scale (GSRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in the Digestion-associated Quality of Life Questionnaire (DQLQ)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cessation of SE within 30 minutes of IP initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No escalation of treatment for persistent or recurrent SE within 36 hours of IP initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proprioception Assessment-1 (self-reported)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proprioception assessment-2
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Graded Redefined Assessment of Strength, Sensation, and Prehension version 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Capabilities of Upper Extremity Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grip and Pinch Force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Movement and gait disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of acute toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Injection Pain
Endpoint domain: Adverse events/effects
Primary endpoint: Tenderness
Endpoint domain: Adverse events/effects
Primary endpoint: Soreness
Endpoint domain: Adverse events/effects
Primary endpoint: Change in SOTIPS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in concentration of IgE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in forearm blood flow (FBF) response to acetylcholine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in 24 hour-ambulatory systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area under the plasma concentration-time curve from time zero extrapolated to infinite time (AUC[INF])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ECG signal quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Distance covered in six-minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HER2 status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Reduction of synovium thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Character strengths
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients achieving motor milestone of sit unassisted for at least 10 seconds at 18 months of age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with successful arterial revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Incidence of all symptomatic intracerebral hemorrhage (sICH)
Endpoint domain: Adverse events/effects
Primary endpoint: Thoracic cavity volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RBC/barrier signal ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relief rate of depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor Response at 2 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Tumor Response at 4 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Tumor Response at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of subjects subject to surgical resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Durable Virologic Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time To Next Treatment (TTNT)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Area under the curve of baseline blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Minor opportunistic infections or AIDS-defining conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Hamilton Rating Scale for Depression (HRSD-17) Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of retention in the trial
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Recurrence rate of reherniation/restenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postural Stability Testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the 1-minute sit-to-stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EASI 75 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in lymphatic flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in volumetric measurement of the arm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional brain changes as monitored by fMRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mystical Experience Questionnaire (MEQ)-30 scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Brain activity changes as assessed by qEEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Toxicity as measured by NCI CTC v2.0
Endpoint domain: Adverse events/effects
Primary endpoint: Modulation of serum prostate-specific antigen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cellular proliferation as measured by proliferating cell nuclear antigen (PCNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Effectiveness of device success in managing hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Ringer related thrombosis and/or dissection
Endpoint domain: Adverse events/effects
Primary endpoint: KCCQ-12
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in state body satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Tooth movement speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: omics differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: microbial feature differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Air conduction thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in crestal peri-implant bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor associated proteins expression level of exosomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: IH-OUS score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Severe Hypoglycemic Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Diabetic Ketoacidosis Events
Endpoint domain: Adverse events/effects
Primary endpoint: EEG theta and gamma wave measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Ability to perform block building task
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Ability to choose among unfolded three-dimensional objects
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in AOFAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Level of serum elafin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Device Oriented Composite Endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in REBC hemolysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of flushing interventions to address occlusions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Higher order cognitive abilities
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Psycho-emotional abilities
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Functional profile
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Brain profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Acidity level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Index of reflux symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endoscopic laryngoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Forced Oscillation Technique (FOT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Prevalence of patient-specific somatic alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pulse Rate Verification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Respiration Rate Verification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Copeptin Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes